Lukasiewicz Michael, Falissard Bruno, Michel Laurent, Neveu Xavier, Reynaud Michel, Gasquet Isabelle
INSERM, U669, Paris, F-75014 France.
Subst Abuse Treat Prev Policy. 2007 Jan 4;2:1. doi: 10.1186/1747-597X-2-1.
Most studies measuring substance-use disorders in prisons focus on incoming or on remand prisoners and are generally restricted to drugs. However, there is evidence that substance use initiation or continuation occurs in prison, and that alcohol use is common. The aim of this study is 1) to assess prevalence of both drug and alcohol abuse and dependence (DAD/AAD) in a national randomised cohort of French prisoners, short or long-term sentence 2) to assess the risk factors associated with DAD/AAD in prison. a stratified random strategy was used to select 1) 23 prisons among the different types of prison 2) 998 prisoners. Diagnoses were assessed according to a standardized procedure, each prisoner being assessed by two psychiatrists, one junior, using a structured interview (MINI 5 plus), and one senior, completing the procedure with an open clinical interview. At the end of the interview the clinicians met and agreed on a list of diagnoses. Cloninger's Temperament and Character Inventory (TCI) was also used.
More than a third of prisoners presented either AAD or DAD in the last 12 months. Cannabis was the most frequent drug and just under a fifth of prisoners had AAD. AAD and DAD were clearly different for the following: socio-demographic variables, childhood history, imprisonment characteristics, psychiatric comorbidity and Cloninger's TCI. Profiles of AAD in prison are similar to type II alcoholism.
Regular screening of AAD/DAD in prison, and specific treatment programmes taking into account differences between prisoners with an AAD and prisoners with a DAD should be a public health priority in prison.
大多数针对监狱中物质使用障碍的研究聚焦于新入狱或还押候审的囚犯,且通常局限于毒品。然而,有证据表明物质使用的起始或持续情况在监狱中存在,并且酒精使用很常见。本研究的目的是:1)评估法国全国随机抽样的短期或长期服刑囚犯队列中药物和酒精滥用及依赖(DAD/AAD)的患病率;2)评估与监狱中DAD/AAD相关的风险因素。采用分层随机策略来选择:1)不同类型监狱中的23所监狱;2)998名囚犯。诊断依据标准化程序进行评估,每位囚犯由两名精神科医生评估,一名初级医生使用结构化访谈(MINI 5 plus),一名高级医生通过开放式临床访谈完成评估流程。访谈结束时,临床医生会面并就诊断清单达成一致。还使用了克隆宁格的气质与性格量表(TCI)。
超过三分之一的囚犯在过去12个月内存在AAD或DAD。大麻是最常使用的毒品,近五分之一的囚犯存在AAD。AAD和DAD在以下方面明显不同:社会人口统计学变量、童年经历、监禁特征、精神疾病共病情况以及克隆宁格的TCI。监狱中AAD的特征与II型酒精中毒相似。
在监狱中定期筛查AAD/DAD,并制定考虑到AAD囚犯和DAD囚犯差异的特定治疗方案,应成为监狱公共卫生的优先事项。